Artemis Medicare FY26 Performance and Expansion Plans

Artemis Medicare Services Ltd. reported its financial and operational performance for the fiscal year ended March 31, 2026, during its recent earnings call.

FY26 Performance Highlights

The company posted a 15.4% year-on-year revenue growth, reaching INR 1,081 crore. Profit After Tax (PAT) saw a significant jump of 26.2%, closing at INR 104 crore. Operational improvements were highlighted, with its Gurugram hospital achieving a 64.6% occupancy rate. Average Revenue Per Bed Per Day (ARPOB) in Q4 FY26 increased by 7.3% year-on-year to INR 84,571. International patient revenue grew by 26.9% for the full year.

Aggressive Expansion Drive and Funding

Artemis Medicare is embarking on a significant growth phase, planning to more than double its current bed capacity from 800 to 2,000 by 2029. This expansion drive is supported by its strong operational performance and a planned fundraising of up to INR 700 crore. These funds will finance new projects beyond the immediate pipeline, supporting the company's strategic shift towards greater capacity. Historically, the company has focused on building its multi-specialty hospital network and enhancing service offerings, with management emphasizing operational efficiency and technology adoption as key growth drivers.

What This Means for Shareholders

Shareholders can anticipate a significant scaling up of the company's operational footprint. New hospital projects in Raipur and South Delhi are slated for commissioning, adding substantial bed capacity. A INR 700 crore fundraising exercise is planned, which could lead to equity dilution but is intended to fuel future growth. The company's long-term financial targets include sustained revenue growth and improved Return on Capital Employed (ROCE), a measure of how efficiently capital is used to generate profits.

Potential Risks to Monitor

• Geopolitical Sensitivity: International patient volumes remain vulnerable to regional conflicts, as seen in a temporary dip during Q4.
• Initial Expansion Losses: New facilities like Raipur are expected to incur operating losses for the first 15-18 months, potentially impacting blended margins.
• Execution Risk: The ambitious plan to scale from 800 to 2,000 beds necessitates disciplined capital management and timely project execution to avoid delays or cost overruns.

Industry Peers and Market Position

Artemis Medicare's expansion strategy aligns with industry peers like Apollo Hospitals, Fortis Healthcare, and Max Healthcare, which are also pursuing aggressive growth. While Artemis's current scale is smaller, its planned doubling of capacity signals a move to compete more directly with larger players.

Looking Ahead: Key Metrics to Watch

• Progress on the upcoming Raipur and South Delhi hospital projects.
• Successful completion of the INR 700 crore fundraising.
• Management's ability to control initial losses at new facilities and achieve planned operational efficiency.
• Recovery and sustained growth in international patient numbers.
• Performance against long-term revenue growth (15-17%) and ROCE (16-18%) targets.